UTRS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
UTRS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Minerva Surgical's basic earnings per share (Basic EPS) for the three months ended in Sep. 2023 was $-0.81. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2023 was $-8.33.
Minerva Surgical's EPS (Diluted) for the three months ended in Sep. 2023 was $-0.81. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-8.33.
Minerva Surgical's EPS without NRI for the three months ended in Sep. 2023 was $-0.81. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2023 was -8.33.
During the past 3 years, the average EPS without NRI Growth Rate was 16.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 4 years, Minerva Surgical's highest 3-Year average EPS without NRI Growth Rate was 16.00% per year. The lowest was 16.00% per year. And the median was 16.00% per year.
The historical data trend for Minerva Surgical's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minerva Surgical Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
EPS (Basic) | -56.14 | -17.91 | -61.20 | -23.60 |
Minerva Surgical Quarterly Data | |||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
EPS (Basic) | Get a 7-Day Free Trial | -7.92 | -4.12 | -2.40 | -1.00 | -0.81 |
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Minerva Surgical's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as
Basic EPS (A: Dec. 2022 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (-34.112 | - | 0) | / | 1.440 | |
= | -23.69 |
Minerva Surgical's Basic EPS for the quarter that ended in Sep. 2023 is calculated as
Basic EPS (Q: Sep. 2023 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (-7.181 | - | 0) | / | 8.873 | |
= | -0.81 |
EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.33
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minerva Surgical (OTCPK:UTRS) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of Minerva Surgical's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Cohen | director | C/O ACCELMED, 848 BRICKELL AVE, #901, MIAMI FL 33131 |
Accelmed Partners Ii L.p. | 10 percent owner | 2875 NE 191ST, SUITE 500, AVENTURA FL 33180 |
New Enterprise Associates 13 Lp | 10 percent owner | 1119 ST PAUL STREET, BALTIMORE MD 21202 |
Uri Geiger | director, 10 percent owner | 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815 |
Todd Usen | director, officer: Chief Executive Officer | C/O MINERVA SURGICAL, INC., 4255 BURTON DRIVE, SANTA CLARA CA 95054 |
Derrick Sung | director | C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103 |
David M Clapper | director, officer: President and CEO | 3003 TASMAN DRIVE, SANTA CLARA CA 95054 |
Novo Holdings A/s | 10 percent owner | TUBORG HAVNEVEJ 19, HELLERUP G7 2900 |
Jaffe Ross A Md | director | ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104 |
Evgueni V. Skalnyi | officer: VP Medical Affairs | C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054 |
Dominique J. Filloux | officer: COO | C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054 |
Joel R Jung | officer: CFO | 1401 HARBOR BAY PARKWAY, ALAMEDA CA 94502 |
Niquette L. Hunt | director | SOLITON, INC., 5304 ASHBROOK DRIVE, HOUSTON TX 77081 |
Jill Anderson | director | 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095 |
Nea Partners 13, Limited Partnership | 10 percent owner | 1119 ST. PAUL STREET, BALTIMORE MD 21202 |
From GuruFocus
By sperokesalga sperokesalga • 04-18-2023
By GuruFocusNews GuruFocusNews • 01-04-2022
By GuruFocusNews GuruFocusNews • 04-27-2022
By sperokesalga sperokesalga • 03-21-2023
By PurpleRose PurpleRose • 07-21-2022
By GuruFocus Research GuruFocus Editor • 05-11-2022
By Stock market mentor Stock market mentor • 01-03-2023
By PurpleRose PurpleRose • 07-28-2022
By GlobeNewswire GlobeNewswire • 12-27-2022
By GuruFocusNews GuruFocusNews • 02-22-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.